Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:30 AM
Ignite Modification Date:
2025-12-25 @ 2:30 AM
NCT ID:
NCT06275334
Eligibility Criteria:
Inclusion Criteria:
* Subjects aged 2 years to 25 years
* Male or female gender
* Subjects suffering from neuroblastoma and treated at the HUS or at the Oncopole center in Toulouse during the period from January 1, 1998 to December 31, 2023.
* Subject (and/or holders of parental authority) not opposing, after information, the reuse of the child's data for the purposes of this research and agreeing to respond to the quality of life survey.
Exclusion Criteria:
* Patient or parents of the minor having expressed their opposition to participating in the study.
* specific clinical forms of the disease,
* interfering treatments and associated diseases.
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
25 Years
Study:
NCT06275334
Study Brief:
Protocol Section:
NCT06275334